Related Experiment Video
Updated: Jul 6, 2026
11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
A simple immunomonitoring procedure for mRNA-loaded dendritic cell therapy
Mikako Hiura1, Koji Ueno, Yutaka Suehiro
1Department of Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Summary
Messenger RNA (mRNA) transfected cells can stimulate T cells for dendritic cell therapy. This method shows potential for monitoring mRNA-based immunotherapies by detecting interferon-gamma producing T cells.
Area of Science:
- Immunology
- Cell Therapy
- Molecular Biology
Background:
- Dendritic cell (DC) therapy holds promise for treating various diseases.
- Monitoring the efficacy of DC therapy, especially those using messenger RNA (mRNA) as antigen, is crucial.
- Developing simple and effective immunomonitoring methods is essential for clinical application.
Purpose of the Study:
- To establish a straightforward immunomonitoring technique for mRNA-based dendritic cell therapy.
- To assess the potential of mRNA-transfected peripheral blood mononuclear cells (PBMCs) in stimulating T cell responses.
- To investigate the induction of interferon-gamma (IFN-γ)-producing T cells using Mycobacterium tuberculosis antigen 85A (Ag85A) mRNA.
Main Methods:
- Co-culturing PBMCs from healthy donors with autologous PBMCs transfected with Ag85A mRNA.
- Quantifying IFN-γ-producing T cells using flow cytometry.
- Implementing a week-long in vitro primary induction for non-responsive donors, followed by restimulation.
Main Results:
- IFN-γ-producing CD4+ and CD8+ T cells were detected in a subset of donors after overnight co-culture.
- A significant induction of IFN-γ-producing CD8+ T cells was achieved after a week of in vitro primary induction and restimulation.
- The T cell response was mediated by both MHC class I and class II pathways, with a stronger dependence on class II and IL-12.
Conclusions:
- Ag85A mRNA-transfected PBMCs can effectively induce specific IFN-γ-producing T cells.
- This approach shows promise as a viable method for immunomonitoring mRNA-loaded dendritic cell therapies.
- Further research may validate this method for clinical immunomonitoring applications.
